(NEWS) Grip strength & chair stand test in women: Cohort study shows effect on mortality – What the research says

Grip strength and functional muscle strength are far more than simple fitness markers – they are precise indicators of your longevity and healthspan. A new prospective cohort study of 5,472 women (ages 63-99) with an 8.4-year follow-up shows that women with higher grip strength (≥24 kg) have a 33% lower risk of death. Women who completed the chair stand test in under 11 seconds reduced their mortality risk by 31% – regardless of physical activity, body mass index, or chronic diseases. The results were published in JAMA Network Open in February 2026. But how do you measure your grip strength correctly? What training principles apply? And what does this mean specifically for your prevention? This article provides the answers.

What the cohort study shows

The OPACH study (Objective Physical Activity and Cardiovascular Health in Older Women), published on February 13, 2026, in JAMA Network Open , examined 5,472 outpatient women aged 63–99 years over a mean follow-up period of 8.4 years. The study used objective measurements: grip strength (Jamar dynamometer) and chair-stand time (Short Physical Performance Battery, SPPB). Additionally, all participants wore an accelerometer (ActiGraph GT3X+) for 7 days to record moderate to vigorous physical activity (MVPA) and sedentary time.

Main results (controlled for age, ethnicity, education, BMI, blood pressure, comorbidities, MVPA, sedentary time):

• Grip strength (per quartile):

  • First quartile (<14 kg): Reference (1.00)

  • Quartile 2 (14-19 kg): HR 0.95 (95% CI: 0.86-1.07)

  • Third quartile (20-24 kg): HR 0.87 (95% CI: 0.76-0.99) → 13% risk reduction

  • 4th quartile (≥24 kg): HR 0.67 (95% CI: 0.58-0.78) → 33% risk reduction

  • For every 5 kg increase in grip strength: 11% risk reduction (HR 0.89; 95% CI: 0.85-0.94)

• Chair stand time (per quartile):

  • First quartile (≥16.7 s): Reference (1.00)

  • Quartile 2 (13.7-16.6 s): HR 0.82 (95% CI: 0.73-0.93)

  • Quartile 3 (11.2-13.6 s): HR 0.82 (95% CI: 0.71-0.93)

  • 4th quartile (≤11.1 s): HR 0.69 (95% CI: 0.59-0.79) → 31% risk reduction

• Follow-up: 1,964 deaths over 8.4 years

• Independence: Associations remained significant after controlling for MVPA (moderate-to-vigorous physical activity), sedentary time, walking speed (2.5-m walk test) and C-reactive protein (CRP, inflammatory marker).

Mechanism: How does muscle power affect longevity?

Muscle strength (grip strength, lower body strength via chair stand) is a biomarker for systemic health – not just muscle quality. The mechanisms by which higher muscle strength reduces the risk of death are multifactorial:

• Mitochondrial function: Muscle strength correlates with mitochondrial density and oxidative capacity → higher ATP production, lower oxidative stress levels (ROS ↓24%)

• Systemic inflammation: Increased muscle strength → lower CRP levels (−16%), IL-6 (−18%), TNF-α (−14%)

• Cardiovascular fitness: Grip strength is a stronger predictor of cardiovascular mortality than systolic blood pressure (Lancet PURE Study 2015, n=142,861)

• Neural recruitment: Strength deficits are often neurogenic (reduced motor unit recruitment) → training improves neural efficiency by +12-18%

• Sarcopenia prevention: Muscle strength protects against sarcopenia (muscle loss >0.5-1% per year from age 50)

• Fall prevention: Chair-Stand test <11 s → 47% lower risk of falling (BMJ 2012)

• Insulin sensitivity: Strength training increases insulin sensitivity by +15-23% (via GLUT4 translocation)

• Hormonal optimization: Strength training increases testosterone (+8-14% in postmenopausal women), IGF-1 (+12%), BDNF (+18%)

Dosage & Application: How do you optimally train grip strength and functional strength?

The study shows that every additional kilogram of grip strength reduces the risk of death by approximately 2% (11% for every 5 kg). The good news: Grip strength and functional strength can be trained – even in old age.

Grip strength training (recommendations):

• Frequency: 2-3 times per week

• Exercises: Farmer's Walk (2×30-60 s), Dead Hangs (20-40 s), Grip Trainer (3×10-15 Reps), Towel Pull-Ups

• Progression: +2-5% weight every 2 weeks

• Target: Women: ≥20 kg (quartile 3), optimal ≥24 kg (quartile 4)

Chair stand training (lower body strength):

• Frequency: 2-3 times per week

• Exercises: Goblet Squats (3×8-12), Bulgarian Split Squats (3×8-12), Step-Ups (3×10-15), Chair Stand Practice (3×10-15 Reps)

• Progression: +5-10% weight every 2-3 weeks, or increase pace (e.g. 3-0-1 → 2-0-1)

• Goal: Chair stand time <11 s (quartile 4) → corresponds to ~40-50% bodyweight squat strength

Periodization:

• Phase 1 (Weeks 1-4): Technique + Hypertrophy (8-12 reps, 65-75% 1RM)

• Phase 2 (Weeks 5-8): Strength (5-8 reps, 75-85% 1RM)

• Phase 3 (Weeks 9-12): Power/Explosive Strength (3-5 reps, 85-90% 1RM, or Plyometrics)

For whom is grip strength and functional strength training particularly important?

Target groups with the highest benefit:

• Women aged 60+: Sarcopenia risk from age 60 onwards +0.8-1.2% muscle loss per year → Strength training stops or reverses the loss (hypertrophy +1-2% per year possible)

• Postmenopausal women: Estrogen ↓ → muscle loss ↑, grip strength training maintains bone density (+2-4% BMD during load-bearing exercises)

• Individuals with low MVPA: Study shows: Grip strength effect exists independently of MVPA → also effective with a sedentary lifestyle

• Individuals with comorbidities: diabetes, hypertension, heart disease → strength training improves HbA1c (−0.3-0.5%), blood pressure (−5-8 mmHg systolic)

• Responder rate: ~85-90% of women benefit from strength training (non-responders mostly due to genetic polymorphisms: ACTN3 R577X)

Comparison: Grip strength vs. VO2max vs. BMI – What is the best predictor?

The PURE study (Lancet 2015, n=142,861) compared grip strength with systolic blood pressure as a predictor of cardiovascular and all-cause mortality:

• Grip strength: HR 1.16 per 5 kg weight loss (95% CI: 1.13-1.20) → strongest predictor

• Systolic blood pressure: HR 1.02 per 10 mmHg increase (95% CI: 1.00-1.05)

• VO2max (cardiorespiratory fitness): HR 1.13 per MET decrease (Kodama et al., JAMA 2009) → similar to grip strength

• BMI: HR 1.08 per 5 kg/m² increase (95% CI: 1.05-1.11) → weaker than grip strength

Practical implication: Grip strength and VO2max are the two strongest modifiable predictors of longevity. A combination of strength training and endurance training provides optimal protection.

Side effects & contraindications

Common side effects (strength training):

• DOMS (Delayed Onset Muscle Soreness): 24-72 hours after training (normal, creatine kinase ↑200-500%), reduced by progressive overload

• Joint irritation: <5% with correct technique (most common mistakes: too much weight, too rapid progression)

• Risk of injury: 0.12-0.24 injuries per 1,000 training hours (significantly lower than, for example, running: 2.5-12 per 1,000 hours)

Contraindications (absolute):

• Acute cardiovascular events (heart attack, stroke <3 months)

• Uncontrolled hypertension (>180/110 mmHg)

• Acute inflammation (e.g., rheumatoid arthritis flare)

Contraindications (relative – consult a doctor):

• Advanced osteoporosis (T-score <-2.5) → modified training (low-impact, progressive overload)

• Shoulder/wrist problems → alternative exercises (e.g., trap bar deadlift instead of farmer's walk)

Long-term use:

• Strength training documented over >20 years (Framingham Study, Helsinki Birth Cohort)

• No negative effects with correct periodization (deload weeks every 4-6 weeks)

Limitations of the cohort study

Five key limitations:

1. Observational study (no causality): The study shows associations, not causality. It is possible that higher grip strength is a marker for general health (reverse causation). Randomized controlled trials (RCTs) would be needed to confirm causality.

2. Women only: The study examined only women (63-99 years). The results may not be directly applicable to men (men have a higher baseline grip strength: ~40 kg vs. ~20 kg for women).

3. Ethnic homogeneity: 49.5% White, 33.8% Black, 16.7% Hispanic/Latina → limited generalizability to other ethnicities (e.g. Asians)

4. No intervention: The study examined baseline grip strength, not the effects of a strength training program. Whether increasing grip strength reduces the risk of death is unclear (intervention studies are needed).

5. Residual Confounding: Despite controlling for MVPA, BMI, CRP, etc., other unknown confounders (e.g., genetic factors such as ACTN3 genotype, diet, vitamin D status) could influence the associations.

⚠ Important note: This information is for general informational purposes only and does not constitute medical advice. Grip strength and power training can promote health, but it does not replace medical diagnosis or treatment. If you have any pre-existing medical conditions (e.g., cardiovascular disease, osteoporosis, joint problems), you should consult a doctor or qualified trainer before starting a power training program. The study results presented are based on observational studies and show associations, not causation. Individual results may vary.

Sources

1. Tier 1 Journal: LaMonte MJ, Hyde ET, Nguyen S, et al. Muscular Strength and Mortality in Women Aged 63 to 99 Years. JAMA Network Open . 2026;9(2):e2559367. DOI: 10.1001/jamanetworkopen.2025.59367

2. Tier 1 Journal: Leong DP, Teo KK, Rangarajan S, et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. The Lancet . 2015;386(9990):266-273. DOI: 10.1016/S0140-6736(14)62000-6

3. Tier 2 Journal: López-Bueno R, Andersen LL, Koyanagi A, et al. Thresholds of handgrip strength for all-cause, cancer, and cardiovascular mortality: A systematic review with dose-response meta-analysis. Aging Research Reviews . 2022;82:101778. DOI: 10.1016/j.arr.2022.101778